Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aletheia Therapeutics
Seattle, Washington, United Statesaletheiapllc.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Aletheia Therapeutics was a clinical-stage oncology therapeutics company focused on developing new approaches to cancer treatment. The company advanced research and development programs aimed at addressing various cancer types and was acquired by Immune Therapeutics in December 2019. Specific clinical results are not publicly detailed.
- Therapeutic areas
- Oncology
- Industry
- Biotech
Beyond the preview
Go deeper on Aletheia Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aletheia Therapeutics.